Dark Forest Capital Management’s Amedisys AMED Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-83,111
Closed -$8.18M 1139
2025
Q2
$8.18M Buy
83,111
+75,309
+965% +$7.13M 0.33% 31
2025
Q1
$723K Buy
+7,802
New +$719K 0.03% 816
2024
Q2
Sell
-5,584
Closed -$515K 648
2024
Q1
$515K Sell
5,584
-1,421
-20% -$133K 0.09% 267
2023
Q4
$666K Buy
+7,005
New +$654K 0.1% 178
2023
Q2
Sell
-13,834
Closed -$1.02M 1027
2023
Q1
$1.02M Buy
13,834
+13,819
+92,127% +$1.2M 0.24% 78
2022
Q4
$1.25K Sell
15
-201
-93% -$18.1K ﹤0.01% 974
2022
Q3
$21K Buy
+216
New +$25.8K ﹤0.01% 618
2022
Q1
Sell
-32
Closed -$5K 1249
2021
Q4
$5K Buy
+32
New +$5.14K ﹤0.01% 1136
2021
Q3
Sell
-32
Closed -$8K 1242
2021
Q2
$8K Buy
+32
New +$8.4K ﹤0.01% 654

Other funds holding AMED

Dark Forest Capital Management's AMED Position: Q3 2025 in Review

Dark Forest Capital Management sold out of Amedisys (AMED) in Q3 2025, closing a stake of 83,111 shares — an estimated $8.18M sold.

Dark Forest Capital Management first reported a position in AMED in Q2 2021 and held it in 9 quarters. The position peaked at $8.18M in Q2 2025. 4 funds tracked by Wall St. Rank hold AMED as of Q3 2025.

  • Dark Forest Capital Management reported no remaining Amedisys position as of Q3 2025 after selling out during the quarter.
  • Dark Forest Capital Management sold 83,111 Amedisys shares in Q3 2025, an estimated $8.18M.
  • Dark Forest Capital Management first reported a position in Amedisys in Q2 2021 and held it in 9 quarters.
  • Dark Forest Capital Management's Amedisys position peaked at $8.18M in Q2 2025.
  • 4 funds tracked by Wall St. Rank held Amedisys as of Q3 2025.

Based on Dark Forest Capital Management's 13F filing for Q3 2025, filed 14 Nov 2025.